摘要
目的:探讨爱维治对糖尿病多发性末梢神经病变的治疗效果。方法:把89例病人随机分为两组,对照组46例应用川芎嗪治疗,治疗组43例在应用川芎嗪的基础上加用爱维治治疗,疗程为15天。结果:对照组总有效率为80%,显效率17%;治疗组总有效率为95%,显效率44%,两组间有显著差异(P<0.05)。结论:爱维治是治疗该病的有效药物。
Objective: To observe the therapeutic effects of actovegin for the treatment of diabetic distal polyneuropathy. Methods: 89 cases with diabetic distal polyneuropathy were divided randomly into two groups: the control group ( n =46) and the treatment group ( n =43). The control and the treatment group were treated with tetramethylpyrazine or with tetramethylpyrazine and actovegin for 15 days respectively. Results: The total effective rate and the significant effective rate were 80% and 17% in the control group; 95% and 44% in the treatment group respectively. There was a significant difference between the two groups ( P <0.05). Conclusion: Actovegin might be an effective drug for the treatment of diabetic distal polyneruropathy.
出处
《新医学》
1999年第5期262-262,287,共2页
Journal of New Medicine